L
Leo E. Otterbein
Researcher at Beth Israel Deaconess Medical Center
Publications - 228
Citations - 24913
Leo E. Otterbein is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Heme oxygenase & Heme. The author has an hindex of 79, co-authored 221 publications receiving 22713 citations. Previous affiliations of Leo E. Otterbein include Veterans Health Administration & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Carbon Monoxide Preserves Circadian Rhythm to Reduce the Severity of Subarachnoid Hemorrhage in Mice.
Nils Schallner,Judith-Lisa Lieberum,David Gallo,Robert H. LeBlanc,Patrick M. Fuller,Khalid A. Hanafy,Leo E. Otterbein +6 more
TL;DR: Clock gene expression regulates, in part, the severity of SAH and requires myeloid HO-1 activity to clear the erythrocyte burden and inhibit neuronal apoptosis and thus merits further investigation in patients with SAH.
Journal ArticleDOI
Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling
Kavita Bisht,Barbara Wegiel,Jens Tampe,Oliver Neubauer,Karl-Heinz Wagner,Leo E. Otterbein,Andrew C. Bulmer +6 more
TL;DR: Biliverdin mitigates LPS-dependent C5aR expression in macrophages in part via mTOR and promotes phosphorylation of Akt and PS6 and decreases L PS-mediated induction of C 5aR-associated cytokines.
Patent
Methods of treating vascular disease
TL;DR: In this paper, a method of treating patients suffering from, or at risk for, intimal hyperplasia and/or arteriosclerosis was proposed, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient.
Journal ArticleDOI
Differential Modulation by Exogenous Carbon Monoxide of TNF-α Stimulated Mitogen-Activated Protein Kinases in Rat Pulmonary Artery Endothelial Cells
TL;DR: In this article, the authors showed that carbon monoxide (CO), a major catalytic byproduct of HO-1, may mediate this anti-inflammatory effect by modulating signal transduction pathways, in particular the mitogen-activated protein (MAP) kinase pathway.
Journal ArticleDOI
Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice.
Danielle Morse,Leo E. Otterbein,Simon C. Watkins,Sean Alber,Zhihong Zhou,Richard A. Flavell,Roger J. Davis,Augustine M.K. Choi +7 more
TL;DR: Results indicate that JNK pathways participate in adaptive responses to hyperoxia in mice, which generates an oxidative stress in the mouse lung, which activates the major stress-inducible kinase pathways, including c-Jun NH2-terminal kinase (JNK).